Overview

Low Dose Statins, Ezetimibe and Nutraceuticals

Status:
Unknown status

Trial end date:
2018-03-31

Target enrollment:

Participant gender:

Summary

It remains unknown if the association between moderate to low intensity statin therapy and ezetimibe and nutraceuticals might have a therapeutic role in high-intensity statin intolerant patients

Phase:

Phase 4

Details

Lead Sponsor:

University of Roma La Sapienza

Treatments:

Ezetimibe
Hydroxymethylglutaryl-CoA Reductase Inhibitors